The Pharmacogenetics of Major Depression: Past, Present, and Future

@article{Laje2007ThePO,
  title={The Pharmacogenetics of Major Depression: Past, Present, and Future},
  author={G. Laje and F. McMahon},
  journal={Biological Psychiatry},
  year={2007},
  volume={62},
  pages={1205-1207}
}
23 Citations

Topics from this paper

The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case–control association study
  • 53
  • Highly Influenced
Pharmacogenetics of Antidepressant Drugs: An Update
  • 2
  • PDF
A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression
  • 50
  • PDF
Pharmacogenetic Randomized Trial for Cocaine Abuse: Disulfiram and Dopamine β-Hydroxylase
  • 81
The &kgr;-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial
  • 18
The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice.
  • 42
Baseline mood-state measures as predictors of antidepressant response to scopolamine
  • 29
...
1
2
3
...

References

SHOWING 1-10 OF 22 REFERENCES
Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
  • 123
Epigenetic Marking and Neuronal Plasticity
  • 37
Genetic markers of suicidal ideation emerging during citalopram treatment of major depression.
  • 187
  • PDF
Pharmacogenetic studies of antidepressant response: how far from the clinic?
  • R. Perlis
  • Medicine
  • The Psychiatric clinics of North America
  • 2007
  • 26
...
1
2
3
...